Serum Calprotectin as predictor of Rheumatoid Arthritis disease severity and Mortality
Seimia Chebbi, Denis Mongin, Delphine S Courvoisier, Michael J Nissen, Burkhard Moeller, Raphael Micheroli, Cem Gabay, Nicolas Vuilleumier, Axel Finckh, Matthias Jarlborg
This study evaluates serum calprotectin as a biomarker for disease activity, severity, cardiovascular risk, and mortality in inflammatory rheumatic diseases, finding it to be a better predictor than CRP in certain contexts.
bioRxiv · Nov 3, 2026 · PreprintImmunology